As of June 2024, the FDA has approved a total of 57 biosimilars across 17 unique biological molecules; of the 57 approvals, 39 biosimilars have launched in the U.S. market.
NACDS shares the vital role of the pharmacy and of the total store in delivering nutrition, hunger-relief, health and wellness solutions for all Americans.
